Fulgent Genetics, Inc.
FLGT
$20.31
-$0.21-1.02%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 14.35% | 95.41% | -11.76% | 22.43% | 12.24% |
| Total Depreciation and Amortization | -11.17% | -5.22% | -7.77% | -2.52% | -3.14% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 19.81% | -93.25% | -32.49% | 55.12% | 71.25% |
| Change in Net Operating Assets | -299.49% | 58.23% | -130.44% | -130.11% | 202.40% |
| Cash from Operations | -160.98% | 67.53% | -251.46% | -55.99% | 191.89% |
| Capital Expenditure | -16.32% | -21.64% | -296.85% | -6.59% | -99.41% |
| Sale of Property, Plant, and Equipment | -99.22% | -100.00% | 72.73% | -92.27% | 30.30% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 174.78% | -186.29% | 14.03% | 86.84% | -1,623.11% |
| Cash from Investing | 158.77% | -213.12% | -55.25% | 766.42% | -983.74% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 32.67% | 93.11% | 92.27% | 96.24% | -287.93% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -454.06% | 98.99% | 84.13% | -134.48% | -119.45% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -298.00% | 98.74% | 87.33% | 92.95% | -154.95% |
| Foreign Exchange rate Adjustments | 115.94% | -192.41% | 235.34% | 95.63% | -346.43% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 128.36% | -121.63% | -126.95% | 233.36% | -220.95% |